Hydrogen-rich saline attenuates eosinophil activation in a guinea pig model of allergic rhinitis via reducing oxidative stress.
Shaoqing Yu, Chuanliang Zhao, Na Che, Lin Jing, Rongming Ge · Journal of inflammation (London, England) · 2017
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In guinea pigs, hydrogen-rich saline reduced the ROS and MDA levels and increased SOD level in guinea pigs of AR-hydrogen-rich saline group accompanied with decreased frequency of sneezing and scratches. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in guinea pigs. hydrogen-rich saline reduced the ROS and MDA levels and increased SOD level in guinea pigs of AR-hydrogen-rich saline group accompanied with decreased frequency of sneezing and scratches.
What the Researchers Studied
The researchers studied guinea pigs. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
The guinea pigs were injected with hydrogen-rich saline (Normal-hydrogen-rich saline and AR-hydrogen-rich saline group) or normal saline (control and AR group). hydrogen-rich saline reduced the ROS and MDA levels and increased SOD level in guinea pigs of AR-hydrogen-rich saline group accompanied with decreased frequency of sneezing and scratches. The authors concluded that hydrogen-rich saline may play a protective role in attenuating allergic inflammation, and suppressing the increase and activation of eosinophils in AR possibly through antioxidation effect of hydrogen. Hydrogen, emerging as a novel antioxidant, has been proven effective in selectively reducing ROS in animals models of oxidative damage.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was guinea pigs. The study used a preclinical animal experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.